secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vanda Pharmaceuticals Inc. (VNDA)
CIK:        0001347178
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001193125-24-196481
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 1.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vanda amends Rights Agreement to clarify definitions of Acting in Concert and Beneficial Owner
--------------------------------------------------------------------------------

- Entered Amendment No. 2 to Rights Agreement on August 7, 2024 with Equiniti Trust Company as rights agent.
- Amendment makes punctuation corrections to the definition of 'Acquiring Person'.
- Amends and restates definitions of 'Acting in Concert' and 'Beneficial Owner' for clarifying changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347178/000119312524196481/0001193125-24-196481-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347178/000119312524196481/d862724d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-196481

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer